Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)

US Patent 7935812 · Granted May 3, 2011

Estimated economic value: $57,596,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Short interfering nucleic acid (siNA) compositions2025
Oligonucleotide compositions and methods thereof2025
Technologies for oligonucleotide preparation2025
Compounds, compositions and methods for synthesis2025
Oligonucleotides, compositions and methods thereof2025
Extrahepatic delivery2025
Oligonucleotide compositions and methods of use thereof2025
Modified double-stranded RNA agents2025
Modified double-stranded RNA agents2025
Modified double-stranded RNA agents2025
Modified RNA agents with reduced off-target effect2025
Modified RNA agents with reduced off-target effect2025